“Hope is being able to see that there is a light despite all of the darkness.” Desmond Tutu Desmond Tutu, a South African Anglican bishop and theologian, was known for his work as an anti-apartheid and human rights activist. He died last December 26 in Cape Town,...
Holiday seasons bring time to pause, remember gratitude and give a variety of gifts, not only to loved ones but also to those in need. One gift I’m very thankful for has been the devotion, compassion, and expertise of Patty Jeys PA-C, a seasoned ME/CFS and FM clinician who recently retired from BHC. Having Patty […]
The Researching COVID to Enhance Recovery (RECOVER), is an Initiative of the National Institutes of Health that aims to understand, prevent, and treat post-acute sequelae of SARS-CoV-2 (PASC), including Long COVID. Bateman Horne Center was invited to partner with the...
Improving Lives Today Begins with Education. Regardless of age, education, or experience, learning is the catalyst for change. You cannot influence a process, mindset, or required skill without learning what needs improvement and how to accomplish it. That is why credentialed medical providers are required to refresh and expand their knowledge base. The advent […]
The Bateman Horne Center (BHC) enters the final quarter of 2021, often referred to as the “giving season,” with unprecedented momentum. This year has been transformational in the world of myalgic encephalomyelitis/chronic fatigue syndrome, fibromyalgia, orthostatic...
Incredible people have spent time at BHC as interns, pre-med students, and clinical research coordinators as a waypoint in their educational journeys. As a part of our mission, we hire and train upcoming researchers and medical professionals to help be a product of...
When Cortene contacted BHC with an idea, and an early draft protocol designed to test CT38 as a treatment for ME/CFS, Dr. Suzanne Vernon and I agreed to help them refine the protocol and conduct the trial. The Cortene-funded trial was an FDA and IRB-approved...
Frontiers in Systems Neuroscience published the study results of Cortene Inc's investigational drug CT38 in people with ME/CFS. The trial was conducted at Bateman Horne Center and Suzanne Vernon, PhD, wrote a blog post providing context about the study. Cortene Inc....
In 2018 the Food and Drug Administration approved a physician-sponsored Investigational New Drug (IND) Application, to investigate the safety, tolerability and efficacy of CT38 in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Dr....
Incredible people have spent time at BHC as interns, pre-med students, and clinical research coordinators as a way point in their educational journeys. As a part of our mission, we hire and train upcoming researchers and medical professionals to help be a product of...
“Hope is being able to see that there is a light despite all of the darkness.” Desmond Tutu Desmond Tutu, a South African Anglican bishop and theologian, was known for his work as an anti-apartheid and human rights activist. He died last December 26 in Cape Town,...
Holiday seasons bring time to pause, remember gratitude and give a variety of gifts, not only to loved ones but also to those in need. One gift I’m very thankful for has been the devotion, compassion, and expertise of Patty Jeys PA-C, a seasoned ME/CFS and FM clinician who recently retired from BHC. Having Patty […]
The Researching COVID to Enhance Recovery (RECOVER), is an Initiative of the National Institutes of Health that aims to understand, prevent, and treat post-acute sequelae of SARS-CoV-2 (PASC), including Long COVID. Bateman Horne Center was invited to partner with the...
Improving Lives Today Begins with Education. Regardless of age, education, or experience, learning is the catalyst for change. You cannot influence a process, mindset, or required skill without learning what needs improvement and how to accomplish it. That is why credentialed medical providers are required to refresh and expand their knowledge base. The advent […]
The Bateman Horne Center (BHC) enters the final quarter of 2021, often referred to as the “giving season,” with unprecedented momentum. This year has been transformational in the world of myalgic encephalomyelitis/chronic fatigue syndrome, fibromyalgia, orthostatic...
Incredible people have spent time at BHC as interns, pre-med students, and clinical research coordinators as a waypoint in their educational journeys. As a part of our mission, we hire and train upcoming researchers and medical professionals to help be a product of...
When Cortene contacted BHC with an idea, and an early draft protocol designed to test CT38 as a treatment for ME/CFS, Dr. Suzanne Vernon and I agreed to help them refine the protocol and conduct the trial. The Cortene-funded trial was an FDA and IRB-approved...
Frontiers in Systems Neuroscience published the study results of Cortene Inc's investigational drug CT38 in people with ME/CFS. The trial was conducted at Bateman Horne Center and Suzanne Vernon, PhD, wrote a blog post providing context about the study. Cortene Inc....
In 2018 the Food and Drug Administration approved a physician-sponsored Investigational New Drug (IND) Application, to investigate the safety, tolerability and efficacy of CT38 in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Dr....
Incredible people have spent time at BHC as interns, pre-med students, and clinical research coordinators as a way point in their educational journeys. As a part of our mission, we hire and train upcoming researchers and medical professionals to help be a product of...
